1. Home
  2. GBIO vs AWRE Comparison

GBIO vs AWRE Comparison

Compare GBIO & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • AWRE
  • Stock Information
  • Founded
  • GBIO 2016
  • AWRE 1986
  • Country
  • GBIO United States
  • AWRE United States
  • Employees
  • GBIO 115
  • AWRE N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • AWRE Computer Software: Prepackaged Software
  • Sector
  • GBIO Health Care
  • AWRE Technology
  • Exchange
  • GBIO Nasdaq
  • AWRE Nasdaq
  • Market Cap
  • GBIO 29.2M
  • AWRE 32.7M
  • IPO Year
  • GBIO 2020
  • AWRE 1996
  • Fundamental
  • Price
  • GBIO $0.36
  • AWRE $1.67
  • Analyst Decision
  • GBIO Strong Buy
  • AWRE
  • Analyst Count
  • GBIO 4
  • AWRE 0
  • Target Price
  • GBIO $7.33
  • AWRE N/A
  • AVG Volume (30 Days)
  • GBIO 493.7K
  • AWRE 25.7K
  • Earning Date
  • GBIO 05-07-2025
  • AWRE 04-30-2025
  • Dividend Yield
  • GBIO N/A
  • AWRE N/A
  • EPS Growth
  • GBIO N/A
  • AWRE N/A
  • EPS
  • GBIO N/A
  • AWRE N/A
  • Revenue
  • GBIO $24,556,000.00
  • AWRE $16,576,000.00
  • Revenue This Year
  • GBIO N/A
  • AWRE N/A
  • Revenue Next Year
  • GBIO $10.90
  • AWRE N/A
  • P/E Ratio
  • GBIO N/A
  • AWRE N/A
  • Revenue Growth
  • GBIO 146.47
  • AWRE N/A
  • 52 Week Low
  • GBIO $0.32
  • AWRE $1.35
  • 52 Week High
  • GBIO $4.34
  • AWRE $2.97
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 39.03
  • AWRE 55.81
  • Support Level
  • GBIO $0.36
  • AWRE $1.53
  • Resistance Level
  • GBIO $0.41
  • AWRE $1.77
  • Average True Range (ATR)
  • GBIO 0.04
  • AWRE 0.10
  • MACD
  • GBIO -0.00
  • AWRE 0.01
  • Stochastic Oscillator
  • GBIO 9.09
  • AWRE 58.33

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

Share on Social Networks: